CJC 1295 (no DAC) | 10 MG

CJC-1295 (no DAC) (also known as Mod GRF 1-29 or Modified GRF) is a synthetic tetrasubstituted analog of growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of GHRH with stabilizing modifications for enhanced receptor affinity and stability. Without the Drug Affinity Complex (DAC), it has a short half-life (approximately 30 minutes to 2 hours), mimicking the body's natural pulsatile GH release more closely than longer-acting versions.

In research, CJC-1295 (no DAC) stimulates the pituitary gland to produce short, potent pulses of endogenous growth hormone (GH), leading to elevated IGF-1 levels in a physiologic pattern—often amplified when combined with a GHRP like Ipamorelin for synergistic effects.

Potential human benefits (drawn from pharmacokinetic studies showing GH/IGF-1 increases, limited clinical observations, and extensive anecdotal reports in fitness, anti-aging, recovery, and wellness communities):

• Lean muscle growth and strength — supports protein synthesis, muscle repair, hypertrophy, and improved physical performance through repeated GH pulses.
• Fat loss and body recomposition — enhances lipolysis, metabolic rate, and fat oxidation for reduced body fat while preserving lean mass—popular for cutting or lean gains.
• Accelerated recovery and tissue repair — faster healing from workouts, injuries, or strains; reduced soreness; and quicker return to training.
• Improved sleep quality and energy — many users report deeper, more restorative sleep (leveraging nighttime GH pulses) and sustained vitality throughout the day.
• Anti-aging and vitality support — potential for better skin elasticity, collagen production, bone density hints, cognitive clarity, and overall rejuvenation from optimized GH dynamics.
• Metabolic and wellness perks — improved insulin sensitivity, energy levels, stamina, and metabolic health without broad hormonal disruption.

Human evidence primarily demonstrates dose-dependent GH pulses and IGF-1 elevation in healthy adults, with benefits often described as more "natural" and targeted compared to continuous-release analogs. Large-scale, long-term randomized trials on body composition remain limited, with most reports anecdotal and synergistic with diet/exercise.

Important Notice:

This product is intended for research use only.
Not for human or animal use of any kind.
Not a drug. Not approved for clinical or therapeutic use.

This product is intended for research use only.
Not for human or animal use of any kind.
Not a drug. Not approved for clinical or therapeutic use.